3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 3
1
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Sarcoma
2
Ovarian Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Desmoplastic Small Round Cell Tumor
2
Stomach Neoplasms
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Pelvic Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Mesothelioma, Malignant
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Liposarcoma
1
Leukemia, Large Granular Lymphocytic
1
Fallopian Tube Neoplasms
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Interventions
X-Rays
2
sodium thiosulfate
1
Watchful Waiting
1
Specimen Handling
1
Reverse Transcriptase Polymerase Chain Reaction
1
Receptor Protein-Tyrosine Kinases
1
Radiotherapy
1
Proctectomy
1
Platinum
1
Observation
1
Microscopy, Electron
1
Magnetic Resonance Spectroscopy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Folfox protocol
1
Ferrosoferric Oxide
1
Enzyme-Linked Immunosorbent Assay
1
Drug Therapy
1
Doxorubicin
1
Dasatinib
1
Cytoreduction Surgical Procedures
1
Copper
1
Cisplatin
1
Cholecalciferol
1
Cetuximab
1
Capecitabine
1
CYT-6091
1
Biopsy
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Rectal Neoplasms
×
Doxorubicin
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled